Amicus Therapeutics CEO John Crowley
Goldman Sachs Talks
00:00
Novasimwas, a Biotec Company for a Rare Disease Called Fabra Disease
Amartist jurry is the founder and chief executive of amachus. The company has just completed a pivotal phase three study for its drug pompey. It's now moving forward with regulatory submissions for approval. AmArtist jurry: "We don't always get good news in biote but it's nice on a monday"
Transcript
Play full episode
